ANI Pharmaceuticals | ANIP - Debt


ANI Pharmaceuticals reported $620.31M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
ANI Pharmaceuticals USD 620.31M 1.25M Sep/2025
Aurora Cannabis CAD 100.34M 1.29M Sep/2025
Canopy Growth CAD 259.33M 68.47M Sep/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Hikma Pharmaceutical USD 1.56B 252M Jun/2025
Knight Therapeutics CAD 106.24M 1.5M Sep/2025
Novartis USD 32.02B 615M Sep/2025
Perrigo USD 3.65B 454.7M Jun/2025
Sun Pharmaceuticals INR 23.62B 2.1B Mar/2025
Teva Pharmaceutical Industries USD 17.07B 450M Sep/2025